The global riluzole hydrochloride market is expected to grow at a CAGR of XX% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ALS and other neurodegenerative diseases. Riluzole hydrochloride is an FDA-approved drug for the treatment of ALS and has been approved by regulatory authorities in more than 100 countries worldwide.
The global riluzole hydrochloride market is segmented on the basis of type, application, and region. Based on type, it is classified into low purity (below 97%), purity (above 97% and below 99%), high purity (above 99%). Based on application, it includes medical treatment and bioscience research. On the basis of region, it covers North America, Latin America, Europe, Asia Pacific & Middle East & Africa regions.
Riluzole is a drug that has been approved by the FDA for the treatment of amyotrophic lateral sclerosis (ALS). It is also used to treat certain types of seizures.
Industry Growth Insights published a new data on “Riluzole Hydrochloride Market”. The research report is titled “Riluzole Hydrochloride Market research by Types (Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others), By Applications (Medical Treatment, Bioscience Research, Others), By Players/Companies R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences, Sigma-Aldrich”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Riluzole Hydrochloride Market Research Report
By Type
Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others
By Application
Medical Treatment, Bioscience Research, Others
By Companies
R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences, Sigma-Aldrich
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Riluzole Hydrochloride Market Report Segments:
The global Riluzole Hydrochloride market is segmented on the basis of:
Types
Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Treatment, Bioscience Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- R&D Systems
- Abcam
- Stemgent
- Cayman Chemical
- Santa Cruz Biotechnology
- STEMCELL Technologies
- Alfa Chemistry
- Anward
- Race Chemical
- Glentham Life Sciences
- AbMole Bioscience
- Aurum Pharmatech LLC
- Tocris Bioscience
- Enzo Life Sciences
- Sigma-Aldrich
Highlights of The Riluzole Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Purity(Below 97%)
- Purity(Above 97% and Below 99%)
- High Purity(Above 99%)
- Others
- By Application:
- Medical Treatment
- Bioscience Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Riluzole Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Riluzole hydrochloride is a medication used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. It works by slowing the progression of the disease. Riluzole hydrochloride is usually given in combination with other medications, such as steroids, to help improve symptoms and prolong life.
Some of the key players operating in the riluzole hydrochloride market are R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences, Sigma-Aldrich.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Riluzole Hydrochloride Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Riluzole Hydrochloride Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Riluzole Hydrochloride Market - Supply Chain
4.5. Global Riluzole Hydrochloride Market Forecast
4.5.1. Riluzole Hydrochloride Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Riluzole Hydrochloride Market Size (000 Units) and Y-o-Y Growth
4.5.3. Riluzole Hydrochloride Market Absolute $ Opportunity
5. Global Riluzole Hydrochloride Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Riluzole Hydrochloride Market Size and Volume Forecast by Type
5.3.1. Low Purity(Below 97%)
5.3.2. Purity(Above 97% and Below 99%)
5.3.3. High Purity(Above 99%)
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Riluzole Hydrochloride Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Riluzole Hydrochloride Market Size and Volume Forecast by Application
6.3.1. Medical Treatment
6.3.2. Bioscience Research
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Riluzole Hydrochloride Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Riluzole Hydrochloride Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Riluzole Hydrochloride Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Riluzole Hydrochloride Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Riluzole Hydrochloride Demand Share Forecast, 2019-2026
9. North America Riluzole Hydrochloride Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Riluzole Hydrochloride Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Riluzole Hydrochloride Market Size and Volume Forecast by Application
9.4.1. Medical Treatment
9.4.2. Bioscience Research
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Riluzole Hydrochloride Market Size and Volume Forecast by Type
9.7.1. Low Purity(Below 97%)
9.7.2. Purity(Above 97% and Below 99%)
9.7.3. High Purity(Above 99%)
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Riluzole Hydrochloride Demand Share Forecast, 2019-2026
10. Latin America Riluzole Hydrochloride Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Riluzole Hydrochloride Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Riluzole Hydrochloride Market Size and Volume Forecast by Application
10.4.1. Medical Treatment
10.4.2. Bioscience Research
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Riluzole Hydrochloride Market Size and Volume Forecast by Type
10.7.1. Low Purity(Below 97%)
10.7.2. Purity(Above 97% and Below 99%)
10.7.3. High Purity(Above 99%)
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Riluzole Hydrochloride Demand Share Forecast, 2019-2026
11. Europe Riluzole Hydrochloride Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Riluzole Hydrochloride Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Riluzole Hydrochloride Market Size and Volume Forecast by Application
11.4.1. Medical Treatment
11.4.2. Bioscience Research
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Riluzole Hydrochloride Market Size and Volume Forecast by Type
11.7.1. Low Purity(Below 97%)
11.7.2. Purity(Above 97% and Below 99%)
11.7.3. High Purity(Above 99%)
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Riluzole Hydrochloride Demand Share, 2019-2026
12. Asia Pacific Riluzole Hydrochloride Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Riluzole Hydrochloride Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Riluzole Hydrochloride Market Size and Volume Forecast by Application
12.4.1. Medical Treatment
12.4.2. Bioscience Research
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Riluzole Hydrochloride Market Size and Volume Forecast by Type
12.7.1. Low Purity(Below 97%)
12.7.2. Purity(Above 97% and Below 99%)
12.7.3. High Purity(Above 99%)
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Riluzole Hydrochloride Demand Share, 2019-2026
13. Middle East & Africa Riluzole Hydrochloride Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Riluzole Hydrochloride Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Riluzole Hydrochloride Market Size and Volume Forecast by Application
13.4.1. Medical Treatment
13.4.2. Bioscience Research
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Riluzole Hydrochloride Market Size and Volume Forecast by Type
13.7.1. Low Purity(Below 97%)
13.7.2. Purity(Above 97% and Below 99%)
13.7.3. High Purity(Above 99%)
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Riluzole Hydrochloride Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Riluzole Hydrochloride Market: Market Share Analysis
14.2. Riluzole Hydrochloride Distributors and Customers
14.3. Riluzole Hydrochloride Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. R&D Systems
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abcam
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Stemgent
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cayman Chemical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santa Cruz Biotechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. STEMCELL Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alfa Chemistry
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Anward
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Race Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Glentham Life Sciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AbMole Bioscience
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Aurum Pharmatech LLC
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Tocris Bioscience
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Enzo Life Sciences
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Sigma-Aldrich
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
